UK markets closed

The Chemours Company (CC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
23.83-0.74 (-3.01%)
As of 02:42PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.66B
Enterprise value 7.17B
Trailing P/E 4.99
Forward P/E 8.12
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.63
Price/book (mrq)4.86
Enterprise value/revenue 1.23
Enterprise value/EBITDA 68.97

Trading information

Stock price history

Beta (5Y monthly) 1.79
52-week change 3-35.90%
S&P500 52-week change 323.23%
52-week high 339.05
52-week low 315.10
50-day moving average 324.93
200-day moving average 327.07

Share statistics

Avg vol (3-month) 31.27M
Avg vol (10-day) 31.17M
Shares outstanding 5148.9M
Implied shares outstanding 6148.9M
Float 8147.55M
% held by insiders 10.65%
% held by institutions 177.89%
Shares short (28 Jun 2024) 45.14M
Short ratio (28 Jun 2024) 43.33
Short % of float (28 Jun 2024) 45.15%
Short % of shares outstanding (28 Jun 2024) 43.45%
Shares short (prior month 31 May 2024) 45.37M

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 44.07%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 34.07%
5-year average dividend yield 44.24
Payout ratio 431.45%
Dividend date 314 Jun 2024
Ex-dividend date 414 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -5.67%
Operating margin (ttm)8.52%

Management effectiveness

Return on assets (ttm)4.57%
Return on equity (ttm)-33.30%

Income statement

Revenue (ttm)5.84B
Revenue per share (ttm)39.22
Quarterly revenue growth (yoy)-12.10%
Gross profit (ttm)N/A
EBITDA 869M
Net income avi to common (ttm)-331M
Diluted EPS (ttm)-2.22
Quarterly earnings growth (yoy)-64.10%

Balance sheet

Total cash (mrq)746M
Total cash per share (mrq)5.01
Total debt (mrq)4.26B
Total debt/equity (mrq)564.99%
Current ratio (mrq)1.61
Book value per share (mrq)5.05

Cash flow statement

Operating cash flow (ttm)390M
Levered free cash flow (ttm)159.12M